202 related articles for article (PubMed ID: 16197620)
1. An adverse interaction between warfarin and fluoropyrimidines revisited.
Saif MW
Clin Colorectal Cancer; 2005 Sep; 5(3):175-80. PubMed ID: 16197620
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.
Shah HR; Ledbetter L; Diasio R; Saif MW
Clin Colorectal Cancer; 2006 Jan; 5(5):354-8. PubMed ID: 16512995
[TBL] [Abstract][Full Text] [Related]
3. Adverse interaction between capecitabine and warfarin resulting in altered coagulation parameters and bleeding: case report and review of the literature.
Isaacs K; Haim N
J Chemother; 2005 Jun; 17(3):339-42. PubMed ID: 16038530
[TBL] [Abstract][Full Text] [Related]
4. Drug interaction between capecitabine and warfarin: a case report and review of the literature.
Yildirim Y; Ozyilkan O; Akcali Z; Basturk B
Int J Clin Pharmacol Ther; 2006 Feb; 44(2):80-2. PubMed ID: 16502767
[TBL] [Abstract][Full Text] [Related]
5. Warfarin-5-FU interaction--a consecutive case series.
Kolesar JM; Johnson CL; Freeberg BL; Berlin JD; Schiller JH
Pharmacotherapy; 1999 Dec; 19(12):1445-9. PubMed ID: 10600095
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the 5-fluorouracil-warfarin and capecitabine-warfarin drug interactions.
Shah SR; Martin R; Dowell JE; Ussery SM
Pharmacotherapy; 2010 Dec; 30(12):1259-65. PubMed ID: 21128758
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine-warfarin interaction.
Janney LM; Waterbury NV
Ann Pharmacother; 2005 Sep; 39(9):1546-51. PubMed ID: 16014372
[TBL] [Abstract][Full Text] [Related]
8. An adverse interaction between warfarin and capecitabine: a case report and review of the literature.
Copur MS; Ledakis P; Bolton M; Morse AK; Werner T; Norvell M; Muhvic J; Chu E
Clin Colorectal Cancer; 2001 Nov; 1(3):182-4. PubMed ID: 12450435
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
10. Increased anticoagulant activity of warfarin used in combination with doxifluridine.
Nakajima M; Genda T; Suehira M; Satoh H; Miki A; Hori S; Sawada Y
Cancer Chemother Pharmacol; 2010 Oct; 66(5):969-72. PubMed ID: 20107800
[TBL] [Abstract][Full Text] [Related]
11. [Increased INR from concomitant use of acenocoumarol and capecitabine].
Tomlow B; Voll ML; Smorenburg CH
Ned Tijdschr Geneeskd; 2012; 156(26):A4793. PubMed ID: 22759711
[TBL] [Abstract][Full Text] [Related]
12. An observational study examining the impact of capecitabine on warfarin antithrombotic activity and bleeding complications.
Yood MU; Quesenberry CP; Alford SH; Tsai AL; Wells KE; Yood SM; Ackermann Shiff SP
Curr Med Res Opin; 2006 Feb; 22(2):307-14. PubMed ID: 16466602
[TBL] [Abstract][Full Text] [Related]
13. Liver injury possibly related to drug interaction after liver transplant: a case report.
Zhu LQ; Jiang WT; Pan C; Liu YH; Thian Y
J Clin Pharm Ther; 2014 Aug; 39(4):439-41. PubMed ID: 24661191
[TBL] [Abstract][Full Text] [Related]
14. Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.
Camidge R; Reigner B; Cassidy J; Grange S; Abt M; Weidekamm E; Jodrell D
J Clin Oncol; 2005 Jul; 23(21):4719-25. PubMed ID: 16034047
[TBL] [Abstract][Full Text] [Related]
15.
Hasegawa A; Tsujiya Y; Ueda A; Yamamori M; Okamura N
Xenobiotica; 2022 Jun; 52(6):608-612. PubMed ID: 36039774
[TBL] [Abstract][Full Text] [Related]
16. Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer.
Hata T; Kudo T; Sakai D; Takahashi H; Haraguchi N; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M; Satoh T
Cancer Chemother Pharmacol; 2016 Aug; 78(2):389-96. PubMed ID: 27339150
[TBL] [Abstract][Full Text] [Related]
17. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.
Van Cutsem E; Twelves C; Cassidy J; Allman D; Bajetta E; Boyer M; Bugat R; Findlay M; Frings S; Jahn M; McKendrick J; Osterwalder B; Perez-Manga G; Rosso R; Rougier P; Schmiegel WH; Seitz JF; Thompson P; Vieitez JM; Weitzel C; Harper P;
J Clin Oncol; 2001 Nov; 19(21):4097-106. PubMed ID: 11689577
[TBL] [Abstract][Full Text] [Related]
18. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?
Masci G; Magagnoli M; Zucali PA; Castagna L; Carnaghi C; Sarina B; Pedicini V; Fallini M; Santoro A
J Clin Oncol; 2003 Feb; 21(4):736-9. PubMed ID: 12586814
[TBL] [Abstract][Full Text] [Related]
19. Interaction between capecitabine and gemcitabine with warfarin in a patient with pancreatic cancer.
Saif MW; Wasif N
JOP; 2008 Nov; 9(6):739-43. PubMed ID: 18981557
[TBL] [Abstract][Full Text] [Related]
20. Capecitabine-induced potentiation of warfarin.
Buyck HC; Buckley N; Leslie MD; Plowman PN
Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):297. PubMed ID: 12924461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
